Bunce K T, Clayton N M
Br J Pharmacol. 1987 May;91(1):23-9. doi: 10.1111/j.1476-5381.1987.tb08979.x.
The effects of the thromboxane A2-mimetic, U46619, and the thromboxane receptor antagonist, AH23848, on ethanol-induced gastric mucosal damage and gastric non-parietal secretion have been examined in the rat. Oral dosing with U46619 or AH23848 produced a dose-related inhibition of ethanol-induced gastric mucosal damage in the conscious rat, and these effects were partially blocked by indomethacin treatment. Intragastric application of U46619 or AH23848 to the stomach of the anaesthetized rat stimulated the gastric secretion of a juice which consisted principally of Na+ and Cl- ions. These secretagogue effects of both compounds were blocked by indomethacin treatment. These results show that U46619 and AH23848 induce secretory and protective effects in the stomach of the rat, although these responses probably do not involve thromboxane receptors and are mediated, at least in part, by endogenous prostaglandins. The results are discussed in relation to the role of endogenous thromboxane A2 in gastric mucosal protection, and of the possible protective function of non-parietal secretion in the stomach.
在大鼠中研究了血栓素A2模拟物U46619和血栓素受体拮抗剂AH23848对乙醇诱导的胃黏膜损伤及胃非壁细胞分泌的影响。给清醒大鼠口服U46619或AH23848可产生与剂量相关的对乙醇诱导的胃黏膜损伤的抑制作用,且吲哚美辛处理可部分阻断这些作用。向麻醉大鼠胃内应用U46619或AH23848可刺激胃分泌一种主要由Na+和Cl-离子组成的胃液。两种化合物的这些促分泌作用均被吲哚美辛处理所阻断。这些结果表明,U46619和AH23848在大鼠胃中诱导分泌和保护作用,尽管这些反应可能不涉及血栓素受体,且至少部分由内源性前列腺素介导。结合内源性血栓素A2在胃黏膜保护中的作用以及胃中非壁细胞分泌的可能保护功能对结果进行了讨论。